InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-24.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Forbes Alexandria, Présidente-Directrice Générale. Officer active across 1 company, notably MeiraGTx Holdings plc. In total, 18 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €1.9m. History available since 5 March 2021. The latest transaction was disclosed on 24 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
62,000 shares@ US$7.4126.2% of flowOrdinary SharesSEC:0001678604-26-000010:0
6,250 shares0Ordinary SharesSEC:0001678604-25-000010:0
47,500 shares@ US$8.3918.5% of flowOrdinary SharesSEC:0001678604-25-000008:0
47,500 shares@ US$7.9729.0% of flowOrdinary SharesSEC:0001415889-25-019555:0
47,500 shares@ US$5.3417.1% of flowOrdinary SharesSEC:0001415889-25-010444:0
125,000 sharesOrdinary SharesSEC:0001415889-25-005608:0
30,000 sharesOrdinary SharesSEC:0001415889-25-001572:0
62,500 sharesOrdinary SharesSEC:0001415889-25-001338:0
1,000 shares0Ordinary SharesSEC:0001415889-24-010497:0
2,000 shares0Ordinary SharesSEC:0001415889-24-008008:0
30,000 sharesOrdinary SharesSEC:0001415889-24-001431:0
125,000 sharesOrdinary SharesSEC:0001415889-24-000863:0
60,000 sharesOrdinary SharesSEC:0001415889-23-001079:0
48,750 sharesOrdinary SharesSEC:0001415889-23-000741:0
97,500 sharesOrdinary SharesSEC:0001179110-22-000414:0
11,800 shares@ US$19.820.032% mcap18.4% of flowOrdinary SharesSEC:0001179110-21-010256:0
23,821 shares@ US$17.210.055% mcap31.6% of flowOrdinary SharesSEC:0001179110-21-009561:0
1,000 shares0Orindary SharesSEC:0001179110-21-006523:0
18 of 18 declarations
About Forbes Alexandria
Alexandria Forbes is the President and CEO of MeiraGTx Holdings plc. She leads the company in the development of innovative gene therapies. Her role involves guiding the overall strategy of MeiraGTx, with a focus on innovation and research. Alexandria is responsible for managing operations and driving the company's growth in the biotechnology market.
